Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,692,296
+$1,500,886 QoQ
Shares Held
10,699
+95.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,727
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Destination Wealth Management holds $169,220,042 across 8 Drug Manufacturers - General names. ABBV ranks #4 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
280,450 | $71,225,886 | |
| 2 | LLY |
ELI LILLY & Co
|
56,810 | $68,139,623 | |
| 3 | PFE |
Pfizer Inc
|
976,104 | $23,504,584 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,699 | $2,692,296 | |
| 5 | NVO |
Novo Nordisk A S
|
39,942 | $1,914,819 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,119 | $786,291 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,997 | $504,980 | |
| 8 | AMGN |
Amgen Inc
|
1,247 | $451,563 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,692,296 | 10,699 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,191,410 | 5,478 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $532,838 | 2,332 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $523,511 | 2,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $403,352 | 2,173 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $438,525 | 2,093 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $473,748 | 2,666 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $665,310 | 3,369 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $343,726 | 2,004 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $288,628 | 1,585 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $297,697 | 1,921 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $270,692 | 1,816 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $247,768 | 1,839 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $388,862 | 2,440 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $294,938 | 1,825 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $354,851 | 2,644 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $483,219 | 3,155 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $519,400 | 3,204 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $488,252 | 3,606 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $237,853 | 2,205 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $291,962 | 2,592 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $408,963 | 3,779 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $206,585 | 1,928 | Shares | Sole | 2021-02-11 | |
| 2020-03-31 | $241,141 | 3,165 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||